Nearly 100 years after penicillin’s discovery, antibiotics have reached a critical crossroads. Dr. David Thanassi and colleagues have discovered a new potential therapeutic target that may serve as an alternative treatment strategy in light of the antibiotic resistance crisis.
Prof. Andrew Schwartz and colleagues used keywords in social media posts as markers for depression. The findings were compared to clinical outcomes. The result - Facebook posts proved slightly more accurate than standard screening questions in diagnosing depression.
The world’s largest physics organization has elected Trevor Sears based on his advances in the high-resolution spectroscopy of small molecular free radicals, particularly those of importance in combustion chemistry.
To honor the editor and TV commentator’s legacy, the Loeb Professorship will be awarded to an outstanding journalist and will engage students and faculty in the practice and power of digital journalism.
Jules Cohen is a medical oncologist specializing in the use of hormonal treatments and chemotherapy for women with breast cancer. He has a particular interest in developing second-generation PET scans to improve early detection, monitoring and the treatment of breast cancer. In addition, he is studying chemotherapy-induced cognitive impairment (aka “chemobrain”) with the hope of developing novel treatments to prevent this unfortunate side effect. He is involved in the educational efforts of Stony Brook Medicine and contributes to clinical and didactic teaching of medical students, residents in internal medicine, and fellows in hematology and medical oncology.